After further HFD treatment for 4 weeks, although HFD-induced obesity was not significantly influenced by TRAF3 upregulation (Fig. 8f), mice with AdTRAF3 injection clearly exhibited increased fasting glucose and insulin levels but decreased insulin sensitivity and glucose tolerance (Fig. 8g–i). This evidence concerns the gene TRAF3 and obesity disorder.